Steroid sparing drug treatments for polymyalgia rheumatica
Editorial Group: Cochrane Musculoskeletal Group
Published Online: 21 JAN 2009
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Whittle SL, Cole A, Lester S, Hill CL. Steroid sparing drug treatments for polymyalgia rheumatica (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD005325. DOI: 10.1002/14651858.CD005325.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 21 JAN 2009
This is the protocol for a review and there is no abstract. The objectives are as follows:
The main aim of this systematic review is to document the quality and quantity of available evidence on the use of glucocorticoid sparing medications in the treatment of PMR and thus provide a guide for practitioners. Specific objectives are:
- To assess the effectiveness of glucocorticoid-sparing regimens.
This systematic review will also identify important questions for future research to address.